Genetic and phenotypic attributes of splenic marginal zone lymphoma
Ferdinando Bonfiglio(Ceinge Biotecnologie Avanzate (Italy)), Estella Matutes(Institute of Cancer Research), Alessio Bruscaggin(Institute of Oncology Research), Wei Wu(Huazhong Agricultural University), Giorgio Inghirami(Cornell University), Micol Giulia Cittone(Institute of Oncology Research), Alberto J. Arribas(Institute of Oncology Research), Antonino Maiorana(University of Modena and Reggio Emilia), Lodovico Terzi di Bergamo(Institute of Oncology Research), Giuseppe Gritti(Ospedale Papa Giovanni XXIII), Armando López‐Guillermo(Barcelona Supercomputing Center), Luciano Cascione(Institute of Oncology Research), Adalgisa Condoluci(Ente Ospedaliero Cantonale), Gabriela Bastidas(Hospital Clínic de Barcelona), Felicitas Hitz(Kantonsspital St. Gallen), Luca Arcaini(University of Pavia), Renzo Boldorini(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Elisa Lucchini(Ospedale Santa Maria della Misericordia di Udine), Luca Ceriani(St Thomas' Hospital), Francesca Guidetti(Institute of Oncology Research), Maria Cristina Pirosa(Institute of Oncology Research), María Gomes da Silva(Instituto Português de Oncologia Francisco Gentil), Guido Ghilardi(Hospital of the University of Pennsylvania), Angela Rita Elia(Inserm), Deborah Piffaretti(Institute of Oncology Research), Gianluca Gaïdano(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Katia Pini(Institute of Oncology Research), Paolo Corradini(Gruppo di Ricerca Geriatrica), B. Gerber(University of Zurich), Sascha Dietrich(European Molecular Biology Organization), Marco Lucioni(University of Pavia), Anna Guidetti(Fondazione IRCCS Istituto Nazionale dei Tumori), Juan F. Garcı́a(MD Anderson Cancer Center Madrid), Gabriela Forestieri(Institute of Oncology Research), Ricardo Koch(Institute of Oncology Research), Marco Ladetto(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Fabio Facchetti(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), Sı́lvia Beà(Departament de Salut), Roberto Marasca(University of Modena and Reggio Emilia), Martin Faderl(Institute of Oncology Research), Liliana Devizzi(Fondazione IRCCS Istituto Nazionale dei Tumori), Paolo Ghia(Vita-Salute San Raffaele University), L. Bonomini(International Extranodal Lymphoma Study Group), Alessandro Broccoli(Istituto di Ematologia di Bologna), Maria João Baptista(Josep Carreras Leukaemia Research Institute), Sergio Cogliatti(Franklin University), Valeria Spina(Ente Ospedaliero Cantonale), Vincenzo Canzonieri(University of Trieste), Marco Buehler(University Hospital of Zurich), Enrico Derenzini(University of Milan)
Cited by 96
Related Papers
The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma
|New England Journal of Medicine|2002|3.9k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
|New England Journal of Medicine|2018|2.3k
Stromal Gene Signatures in Large-B-Cell Lymphomas
|New England Journal of Medicine|2008|1.8k
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2014|1.7k